Inscrivez-vous 01 49 36 46 20
appel-offre
appel-offre
 
            
Date de publication : 13/05/2022
Date de péremption : 13/06/2022
Type de procédure : Procédure ouverte
Type de document : Avis de marché
NORVÈGE
appel-offre

NorvËge-Oslo: Vaccins antihÈpatite B

2022/S 93-258057  (Source TED)
 
 
V  E  R  S  I  O  N      F  R  A  N  C  A  I  S  E
TX:
13/05/2022 S93 NorvËge-Oslo: Vaccins antihÈpatite B 2022/S 093-258057 Avis de marchÈ Fournitures
 
 
Section I: Pouvoir adjudicateur
I.1) Nom et adresses Nom officiel: Folkehelseinstituttet NumÈro national d'identification: 983 744 516 Adresse postale: Lovisenberggata 8 Ville: OSLO Code NUTS: NO Norge Code postal: 0456 Pays: NorvËge Point(s) de contact: Ole Andreas Fuglesang Courriel: ole.andreas.fuglesang@fhi.no TÈlÈphone: +47 21076629 Adresse(s) internet:
Adresse principale: http://www.fhi.no Adresse du profil díacheteur: https://eu.eu-supply.com/ctm/Company/CompanyInformation/Index/346372
I.3) Communication
Les documents du marchÈ sont disponibles gratuitement en accËs direct non restreint et complet, l'adresse: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=330976&B=DFO Adresse laquelle des informations complÈmentaires peuvent Ítre obtenues: le ou les point(s) de contact susmentionnÈ(s)
Les offres ou les demandes de participation doivent Ítre envoyÈes par voie Èlectronique via: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=330976&B=DFO
Les offres ou les demandes de participation doivent Ítre envoyÈes au(x) point(s) de contact susmentionnÈ(s)
I.4) Type de pouvoir adjudicateur MinistËre ou toute autre autoritÈ nationale ou fÈdÈrale, y compris leurs subdivisions rÈgionales ou locales
I.5) ActivitÈ principale SantÈ
 
 
Section II: Objet
II.1) ...tendue du marchÈ
II.1.1) IntitulÈ:
Hepatitis B vaccines NumÈro de rÈfÈrence: 22/01790
II.1.2) Code CPV principal 33651680 Vaccins antihÈpatite B
II.1.3) Type de marchÈ Fournitures
II.1.4) Description succincte:
The Norwegian Institute of Public Health would like to procure Hepatitis B vaccines for the national vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD). The aim of the procurement is to enter into a contract for the delivery of a vaccine against Hepatitis B for the Norwegian child vaccination programme.
II.1.5) Valeur totale estimÈe Valeur hors TVA: 4 700 000.00 NOK
II.1.6) Information sur les lots Ce marchÈ est divisÈ en lots: non
II.2) Description
II.2.2) Code(s) CPV additionnel(s) 33651600 Vaccins
II.2.3) Lieu d'exÈcution Code NUTS: NO Norge Lieu principal d'exÈcution:
Oslo
II.2.4) Description des prestations:
The Norwegian Institute of Public Health would like to procure Hepatitis B vaccines for the national vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD). The aim of the procurement is to enter into a contract for the delivery of a vaccine against Hepatitis B for the Norwegian child vaccination programme. Children and adolescents in defined risk groups have long been required to be vaccinated against hepatitis B. Norway introduced general Hepatitis B vaccinations in 2016 (applies to children born after 01.11.2016). The target group for pure Hepatitis B vaccines will therefore primarily be previously non-vaccinated children and adolescents in risk groups, born before 01.11.2016, that move to Norway. The childhood vaccination programme includes everyone under 20 years. Available vaccines against Hepatitis B in Norway are found in two dose sizes depending on the persons age (children and adult). The procurement concerns both dose sizes. After the introduction of general vaccination, the need for ëchildren's dosesí is decreasing, but the need for ëadult dosesí is relatively stable. The procurement concerns the delivery of vaccines against Hepatitis B (ATC code: J07B C01) for vaccinating children and adolescents in defined risk groups in the Norwegian child vaccination programme. The following estimates for the annual number of doses required by the Norwegian Public Health Institute are based on statistics for actual distributed doses in the last two years. The estimated annual need for doses for children will be approx. 5000 doses (per calendar year). The estimated annual need for doses for adults will be approx. 3000 doses (per calendar year). The estimated total scope for the contract period, with the full extension of the contract period (option), is estimated to be approx. 20,000 doses for children, and approx. 12,000 doses for adults. The contest has price as the only award criterium.
II.2.5) CritËres díattribution CritËres ÈnoncÈs ci-dessous Prix
II.2.6) Valeur estimÈe Valeur hors TVA: 4 700 000.00 NOK
II.2.7) DurÈe du marchÈ, de l'accord-cadre ou du systËme d'acquisition dynamique DurÈe en mois: 24 Ce marchÈ peut faire l'objet d'une reconduction: oui Description des modalitÈs ou du calendrier des reconductions:
The contract period is 2 years, with an option for 1+1 year extension. The option for an extension will be automatically taken up for one year at a time, unless the contracting authority gives notice on the contract in accordance with the Supply Agreement, point 17. The contracting authority aims to sign the contract shortly after the procurement's waiting period.
II.2.10) Variantes
Des variantes seront prises en considÈration: non
II.2.11) Information sur les options Options: oui Description des options:
The contract period is 2 years, with an option for 1+1 year extension. The option for an extension will be automatically taken up for one year at a time, unless the contracting authority gives notice on the contract in accordance with the Supply Agreement, point 17. The contracting authority aims to sign the contract shortly after the procurement's waiting period.
II.2.13) Information sur les fonds de l'Union europÈenne
Le contrat s'inscrit dans un projet/programme financÈ par des fonds de l'Union europÈenne: non
II.2.14) Informations complÈmentaires There are four (4) minimum requirements for the vaccine. The requirements are given in the tender documentation and in the tender management tool. All the minimum requirements must be fulfilled. Tenders that do not fulfil all of the minimum requirements will be assessed in accordance with the procurement rule's provisions on rejection.
 
 
Section III: Renseignements díordre juridique, Èconomique, financier et technique
III.1)
 
 
Conditions de participation
III.1.1) Habilitation exercer l'activitÈ professionnelle, y compris exigences relatives l'inscription au registre du commerce ou de la profession Liste et description succincte des conditions:
Tenderers must be registered in a company register, professional register or a trade register in the country where the tenderer is established. Documentation requirement: Norwegian companies: Company registration certificate Foreign tenderers: Verification showing that the tenderer is registered in a company register, professional register or a commerce register in the country where the tenderer is established.
III.1.2) CapacitÈ Èconomique et financiËre Liste et description succincte des critËres de sÈlection:
Tenderers must have sufficient economic and financial capacity to comply with the contract. Creditworthiness with no requirement for guarantees will be sufficient to meet the requirement. Documentation requirement: Credit rating based on the most recent accounting figures. The rating must be carried out by a credit rating agency with a licence to provide such service. If a tenderer has valid reasons for not being able to provide the documentation requested by the contracting authority, the tenderer can document his economic and financial capacity by presenting other documents considered suitable by the contracting authority.
III.1.3) CapacitÈ technique et professionnelle Liste et description succincte des critËres de sÈlection:
The tenderer must have sufficient delivery capacity throughout the contract period. Documentation requirement: Confirmation that the tenderer has the capacity to deliver a sufficient number of Hepatitis B vaccine doses to fulfil the contract. The tenderer must have the requisite permissions to be able to fulfil the contract. Documentation requirement: If the tenderer is the manufacturer of the vaccine, permission must be presented from relevant EU/EEA authorities to manufacture pharmaceuticals. If the tenderer is not the manufacturer of the vaccine, the requisite permissions from relevant EU/EEA authorities to trade in pharmaceuticals must be presented. If the tenderer imports the vaccine, the import license that includes the offered vaccine must be presented.
III.2) Conditions liÈes au marchÈ
III.2.2) Conditions particuliËres d'exÈcution:
ï The Norwegian Institute of Public Health requires ethical and socially responsible production. (Supply agreement point 12, 12.1-12.3). ï The tenderer shall be a member of the Legemiddelansvarsforeningen [Pharmaceutical Liability Association] (Supply Agreement, point 11.2) The Norwegian Institute of Public Health can re-sell, non-distributed, vaccine doses (Supply Agreement, point 18.1) ï Tenderers are obliged to deliver up to 5,500 doses for children and 3,000 doses for adults a year in the contract period. (Supply agreement point
   3. 3) ï The Norwegian Institute of Public Health is committed to purchasing a minimum volume during the contract period of 4000 doses for children and 2500 doses for adults a year in the contract period. (Supply agreement point
   3. 2). ï Tenderers are obliged to deliver minimum 2000 doses for children and 1000 doses for adults by 15.12.22 (Supply Agreement point
   3. 4 and
   4. 1).
 
 
Section IV: ProcÈdure
IV.1) Description
IV.1.1) Type de procÈdure ProcÈdure ouverte
IV.1.3) Information sur l'accord-cadre ou le systËme d'acquisition dynamique
IV.1.8) Information concernant líaccord sur les marchÈs publics (AMP)
Le marchÈ est couvert par l'accord sur les marchÈs publics: oui
IV.2) Renseignements d'ordre administratif
IV.2.2) Date limite de rÈception des offres ou des demandes de participation Date: 13/06/2022 Heure locale: 13:00
IV.2.3) Date díenvoi estimÈe des invitations soumissionner ou participer aux candidats sÈlectionnÈs
IV.2.4) Langue(s) pouvant Ítre utilisÈe(s) dans l'offre ou la demande de participation:
anglais, norvÈgien
IV.2.6) DÈlai minimal pendant lequel le soumissionnaire est tenu de maintenir son offre L'offre doit Ítre valable jusqu'au: 13/08/2022
IV.2.7) ModalitÈs díouverture des offres Date: 13/06/2022 Heure locale: 13:05 Lieu:
Electronic tender opening in NPHI's tender management tool.
Informations sur les personnes autorisÈes et les modalitÈs d'ouverture:
Two employees from NPHI with a user licence in the tender management tool will log in and open the tenders.
 
 
Section VI: Renseignements complÈmentaires
VI.1) Renouvellement Il s'agit d'un marchÈ renouvelable: non
VI.3) Informations complÈmentaires:
VI.4) ProcÈdures de recours
VI.4.1) Instance chargÈe des procÈdures de recours Nom officiel: Oslo tingrett Adresse postale: Postboks 2106 Vika Ville: Oslo Code postal: 0125 Pays: NorvËge Courriel: oslo.tingrett@domstol.no TÈlÈphone: +47 22035200 Adresse internet: https://www.domstol.no/Enkelt-domstol/oslotingrett/
VI.5) Date díenvoi du prÈsent avis:
10/05/2022 NorvËge-Oslo: Vaccins antihÈpatite BType díacheteur: MinistËre et toutes autres autoritÈs nationales ou fÈdÈralesType díavis: Avis de marchÈType de procÈdure: ProcÈdure ouverteType de marchÈ: Fournitures 13/06/2022 13/05/2022 NO National
 
 
C L A S S E    C P V
33651600 - Vaccins 
33651680 - Vaccins antihépatite B